Aims: The purpose of this cross-sectional study was to analyse the role of insomnia, vital exhaustion and subjective health in patients diagnosed with Type 2 Diabetes (T2DM). Methods: 279 patients were interviewed and provided sociodemographic information and psychometric self-reported data. Patients were recruited in a diabetes outpatient center at the Sapienza University Hospital in Rome. After the medical visits, participants were invited by physicians to take a structure interview conducted by a junior psychologist in which they completed scales measuring psychological factors related to Diabetes (Sample Diabetes Questionnaire) and other measure on health conditions; Vital-Exhaustion (i.e. lack of stamina and demoralization - VE) and insomnia (Sleep Disorder Questionnaire – SDQ). Results: Most of the patients (81%) described their sleep quality as “poor” or “very poor” (mean on a 4 point Likert scale 2.97 SD=0.63). At the SDQ, symptoms of insomnia were reported by 61.3% of the patients, but only 45 (16.1%) met the criteria for a DSM diagnosis of chronic insomnia, while 93 participants (33.3%) did not complain of any sleep disturbance. The daytime consequences attributed to insomnia were correlated with the number of diabetes symptoms, which correlated with the HbA1c levels, while no correlation between insomnia impact and HbA1c was found. Multiple regression considering the impact of insomnia as an outcome and HbA1c, diabetes symptoms and discomforts, perception of pain and Vital-Exhaustion as predictors, showed that VE was the variable that gave a major contribute to the prediction (β=0.272; p<0.01), followed by the subjective diabetes symptoms (β=0.168; p<0.05). Conclusions: These findings suggest that while a low quality of sleep is frequent among T2DM patients, chronic insomnia is not. The impact of insomnia is related to the number of diabetes symptoms but not to glycometabolic control. The impact of insomnia is explained mostly by the affective condition and by somatization.
Insomnia and Vital-Exhaustion in Patients with Type 2 Diabetes / Violani, Cristiano; PINTO FERNANDES, MARIANA LUÍSA; Smit, Diana; Maes, Stan; De Vincenzo, Conny; Filardi, Tiziana; Morano, Susanna. - STAMPA. - (2015). (Intervento presentato al convegno XXV Congresso Nazionale Associazione Italiana di Medicina del Sonno tenutosi a S.Margherita di Pula, Cagliari nel 1-3 Ottobre).
Insomnia and Vital-Exhaustion in Patients with Type 2 Diabetes
VIOLANI, Cristiano;PINTO FERNANDES, MARIANA LUÍSA;De Vincenzo, Conny;FILARDI, TIZIANA;MORANO, Susanna
2015
Abstract
Aims: The purpose of this cross-sectional study was to analyse the role of insomnia, vital exhaustion and subjective health in patients diagnosed with Type 2 Diabetes (T2DM). Methods: 279 patients were interviewed and provided sociodemographic information and psychometric self-reported data. Patients were recruited in a diabetes outpatient center at the Sapienza University Hospital in Rome. After the medical visits, participants were invited by physicians to take a structure interview conducted by a junior psychologist in which they completed scales measuring psychological factors related to Diabetes (Sample Diabetes Questionnaire) and other measure on health conditions; Vital-Exhaustion (i.e. lack of stamina and demoralization - VE) and insomnia (Sleep Disorder Questionnaire – SDQ). Results: Most of the patients (81%) described their sleep quality as “poor” or “very poor” (mean on a 4 point Likert scale 2.97 SD=0.63). At the SDQ, symptoms of insomnia were reported by 61.3% of the patients, but only 45 (16.1%) met the criteria for a DSM diagnosis of chronic insomnia, while 93 participants (33.3%) did not complain of any sleep disturbance. The daytime consequences attributed to insomnia were correlated with the number of diabetes symptoms, which correlated with the HbA1c levels, while no correlation between insomnia impact and HbA1c was found. Multiple regression considering the impact of insomnia as an outcome and HbA1c, diabetes symptoms and discomforts, perception of pain and Vital-Exhaustion as predictors, showed that VE was the variable that gave a major contribute to the prediction (β=0.272; p<0.01), followed by the subjective diabetes symptoms (β=0.168; p<0.05). Conclusions: These findings suggest that while a low quality of sleep is frequent among T2DM patients, chronic insomnia is not. The impact of insomnia is related to the number of diabetes symptoms but not to glycometabolic control. The impact of insomnia is explained mostly by the affective condition and by somatization.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
